Organizations

BioNTech SE

Covid-19 Vaccines Are in High Demand, but Thousands More Workers Are Needed to Make Them - WSJ

Covid-19 Vaccines Are in High Demand, but Thousands More Workers Are Needed to Make Them

By: Elizabeth Koh
Source: The Wall Street Journal
Date of Publication: January 4th, 2021
Companies mass producing shots for Pfizer, Moderna and AstraZeneca are racing to find staff: ‘We are truly in unprecedented territory’
J&J enrolls about 45,000 participants for late-stage Covid vaccine trial

J&J enrolls about 45,000 participants for late-stage Covid vaccine trial

By: Reuters
Source: CNBC
Date of Publication: December 18th, 2020
Johnson & Johnson said it has enrolled about 45,000 participants for the first late-stage trial of its Covid-19 single-dose vaccine candidate.
Pfizer, U.S. Reach Deal to Boost Covid-19 Vaccine Supply

Pfizer, U.S. Reach Deal to Boost Covid-19 Vaccine Supply

By: Peter Loftus, Rebecca Ballhaus and Matt Grossman
Source: The Wall Street Journal
Date of Publication: December 23rd, 2020
Company will provide 100 million more doses to bolster campaign under way in U.S.
FDA Finds Moderna Covid-19 Vaccine Highly Effective

FDA Finds Moderna Covid-19 Vaccine Highly Effective

By: Thomas M. Burton and Peter Loftus
Source: The Wall Street Journal
Date of Publication: December 15th, 2020
Second major U.S. coronavirus vaccine could possibly be shipped by this weekend.
FDA chief says agency will quickly approve Pfizer's Covid vaccine for emergency use

FDA chief says agency will quickly approve Pfizer’s Covid vaccine for emergency use

By: Noah Higgins-Dunn and Will Feuer
Source: CNBC
Date of Publication: December 11th, 2020
FDA Commissioner Stephen Hahn tweeted Friday that the agency “is finalizing the necessary documents to ensure that patients and providers have the information that they need to make informed decisions.”
Pfizer building

FDA Says Pfizer-BioNTech Vaccine Is Safe, Effective

By: Thomas M. Burton and Jared S. Hopkins
Source: The Wall Street Journal
Date of Publication: December 8th, 2020
The Food and Drug Administration said the first Covid-19 vaccine being considered for U.S. distribution “met the prescribed success criteria” in a clinical study, paving the way for the agency to green-light distribution as early as this weekend.
BioNTech hopes COVID-19 vaccine will immunize for at least a year

BioNTech hopes COVID-19 vaccine will immunize for at least a year

By: Ludwig Burger, Patricia Weiss
Source: Reuters
Date of Publication: November 9th, 2020
BioNTech's BNTX.O co-founder and chief executive said he was optimistic that the protective effect of its experimental COVID-19 vaccine, co-developed with Pfizer PFE.N, would last for at least a year.
Workers at Pfizer’s Kalamazoo, Mich. freezer farm

Pfizer Sets Up Its ‘Biggest Ever’ Vaccination Distribution Campaign

By: Costas Paris and Jared S. Hopkins
Source: The Wall Street Journal
Date of Publication: October 21st, 2020
The U.S. pharmaceutical giant is preparing to ship billions of Covid-19 vaccines using frozen boxes, cargo planes and trucks in a mega logistics operation.
Covid-19 Vaccine Study Results Could Come Late October, Moderna CEO Says - WSJ

Covid-19 Vaccine Study Results Could Come Late October, Moderna CEO Says

By: Peter Loftus
Source: The Wall Street Journal
Date of Publication: September 17th, 2020
Company also released the guidelines for the shot’s final-stage trial.
Vaccine makers pledge safety will be foremost - The Washington Post

Vaccine CEOs issue safety pledge amid Trump’s quest for pre-election approval

By: Christopher Rowland
Source: The Washington Post
Date of Publication: September 8th, 2020
Nine chief executives issued an extraordinary joint statement Tuesday seeking to bolster faith in coronavirus vaccine.